-

Form 8.3 - International Paper Company

LONDON--(BUSINESS WIRE)-- 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

International Paper Company

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16-01-2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes - DS Smith plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Common Stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.0

6,270,218

1.80

(2) Cash-settled derivatives:

 

0

0.0

0

0.0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

7,500

0.001

8,800

0.002

 

TOTAL:

7,500

0.002

6,279,018

1.80

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

Common Stock

Sale

2

56.05

Common Stock

Sale

5

55.76

Common Stock

Sale

12

56.26

Common Stock

Sale

13

55.72

Common Stock

Sale

15

55.48

Common Stock

Sale

19

55.52

Common Stock

Sale

19

55.94

Common Stock

Sale

27

56.06

Common Stock

Sale

39

56.33

Common Stock

Sale

41

55.73

Common Stock

Sale

51

56.25

Common Stock

Sale

55

55.70

Common Stock

Sale

59

56.08

Common Stock

Sale

79

55.85

Common Stock

Sale

89

56.34

Common Stock

Sale

98

55.93

Common Stock

Sale

100

55.95

Common Stock

Sale

100

56.30

Common Stock

Sale

100

56.31

Common Stock

Sale

101

56.16

Common Stock

Sale

102

55.35

Common Stock

Sale

110

56.03

Common Stock

Sale

165

55.71

Common Stock

Sale

187

56.10

Common Stock

Sale

200

55.81

Common Stock

Sale

200

55.88

Common Stock

Sale

214

56.00

Common Stock

Sale

237

55.80

Common Stock

Sale

248

56.07

Common Stock

Sale

271

55.98

Common Stock

Sale

272

55.81

Common Stock

Sale

303

56.11

Common Stock

Sale

307

56.09

Common Stock

Sale

317

56.33

Common Stock

Sale

326

56.24

Common Stock

Sale

357

55.84

Common Stock

Sale

389

55.79

Common Stock

Sale

500

55.89

Common Stock

Sale

504

56.28

Common Stock

Sale

556

56.32

Common Stock

Sale

561

55.75

Common Stock

Sale

676

56.29

Common Stock

Sale

762

55.83

Common Stock

Sale

941

56.30

Common Stock

Sale

942

56.20

Common Stock

Sale

1087

56.31

Common Stock

Sale

1148

56.34

Common Stock

Sale

1660

55.82

Common Stock

Sale

3100

55.59

Common Stock

Sale

24495

56.26

Common Stock

Purchase

5

56.00

Common Stock

Purchase

7

55.36

Common Stock

Purchase

16

55.81

Common Stock

Purchase

20

55.95

Common Stock

Purchase

28

55.32

Common Stock

Purchase

36

55.91

Common Stock

Purchase

42

55.81

Common Stock

Purchase

62

56.31

Common Stock

Purchase

63

56.08

Common Stock

Purchase

80

55.57

Common Stock

Purchase

99

55.67

Common Stock

Purchase

100

55.31

Common Stock

Purchase

100

55.56

Common Stock

Purchase

100

55.65

Common Stock

Purchase

100

55.66

Common Stock

Purchase

100

55.72

Common Stock

Purchase

100

55.73

Common Stock

Purchase

100

55.76

Common Stock

Purchase

100

56.29

Common Stock

Purchase

102

56.09

Common Stock

Purchase

135

56.23

Common Stock

Purchase

151

55.85

Common Stock

Purchase

200

55.38

Common Stock

Purchase

200

55.64

Common Stock

Purchase

200

55.90

Common Stock

Purchase

200

55.92

Common Stock

Purchase

200

56.05

Common Stock

Purchase

210

56.15

Common Stock

Purchase

213

55.94

Common Stock

Purchase

220

55.79

Common Stock

Purchase

266

55.58

Common Stock

Purchase

272

55.37

Common Stock

Purchase

282

55.53

Common Stock

Purchase

301

56.25

Common Stock

Purchase

311

55.61

Common Stock

Purchase

317

56.24

Common Stock

Purchase

318

55.35

Common Stock

Purchase

341

55.96

Common Stock

Purchase

344

56.11

Common Stock

Purchase

375

56.31

Common Stock

Purchase

395

55.51

Common Stock

Purchase

412

55.48

Common Stock

Purchase

446

55.60

Common Stock

Purchase

455

55.63

Common Stock

Purchase

468

56.00

Common Stock

Purchase

476

55.41

Common Stock

Purchase

479

56.07

Common Stock

Purchase

500

55.43

Common Stock

Purchase

500

55.44

Common Stock

Purchase

500

55.93

Common Stock

Purchase

505

55.69

Common Stock

Purchase

511

55.40

Common Stock

Purchase

545

56.10

Common Stock

Purchase

563

56.27

Common Stock

Purchase

582

55.75

Common Stock

Purchase

600

55.49

Common Stock

Purchase

603

55.54

Common Stock

Purchase

615

56.28

Common Stock

Purchase

642

55.52

Common Stock

Purchase

644

55.42

Common Stock

Purchase

648

55.55

Common Stock

Purchase

711

55.70

Common Stock

Purchase

742

55.59

Common Stock

Purchase

752

55.78

Common Stock

Purchase

777

55.74

Common Stock

Purchase

805

56.32

Common Stock

Purchase

824

55.45

Common Stock

Purchase

872

55.73

Common Stock

Purchase

874

56.34

Common Stock

Purchase

894

55.39

Common Stock

Purchase

945

56.06

Common Stock

Purchase

947

55.77

Common Stock

Purchase

1014

55.99

Common Stock

Purchase

1121

55.84

Common Stock

Purchase

1127

55.47

Common Stock

Purchase

1139

55.72

Common Stock

Purchase

1168

55.46

Common Stock

Purchase

1236

55.76

Common Stock

Purchase

1287

55.50

Common Stock

Purchase

1407

55.68

Common Stock

Purchase

1426

55.80

Common Stock

Purchase

1480

55.82

Common Stock

Purchase

1538

55.83

Common Stock

Purchase

1691

55.81

Common Stock

Purchase

1947

55.71

Common Stock

Purchase

2082

56.30

Common Stock

Purchase

2248

56.29

Common Stock

Purchase

2673

56.33

Common Stock

Purchase

56442

56.26

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (USD)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (USD)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

 

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

 

0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

17-01-2025

Contact name:

Janice Falcao

Telephone number:

00442033140679

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:

Qube Research & Technologies Limited

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

International Paper Company

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Common Stock

Call Option IP US 06/20/25 C52.5 Equity

Purchase

2,000

USD 52.5

American

06/20/25

Common Stock

Call Option IP US 04/17/25 C47.5 Equity

Purchase

1,000

USD 47.5

American

04/17/25

Common Stock

Call Option IP US 10/17/25 C42.5 Equity

Purchase

700

USD 42.5

American

10/17/25

Common Stock

Call Option IP US 04/17/25 C52.5 Equity

Purchase

600

USD 52.5

American

04/17/25

Common Stock

Call Option IP US 09/19/25 C42.5 Equity

Purchase

600

USD 42.5

American

09/19/25

Common Stock

Call Option IP US 10/17/25 C55 Equity

Purchase

500

USD 55

American

10/17/25

Common Stock

Call Option IP US 01/16/26 C50 Equity

Purchase

500

USD 50

American

01/16/26

Common Stock

Call Option IP US 01/16/26 C60 Equity

Purchase

300

USD 60

American

01/16/26

Common Stock

Call Option IP US 06/20/25 C50 Equity

Purchase

300

USD 50

American

06/20/25

Common Stock

Call Option IP US 01/17/25 C47.5 Equity

Purchase

200

USD 47.5

American

01/17/25

Common Stock

Call Option IP US 04/17/25 C50 Equity

Purchase

200

USD 50

American

04/17/25

Common Stock

Call Option IP US 01/17/25 C60 Equity

Written

300

USD 60

American

01/17/25

Common Stock

Put Option IP US 04/17/25 P45 Equity

Written

300

USD 45

American

04/17/25

Common Stock

Put Option IP US 01/17/25 P47.5 Equity

Written

400

USD 47.5

American

01/17/25

Common Stock

Call Option IP US 01/17/25 C55 Equity

Written

500

USD 55

American

01/17/25

Common Stock

Put Option IP US 04/17/25 P47.5 Equity

Written

2,400

USD 47.5

American

04/17/25

Common Stock

Put Option IP US 01/16/26 P42.5 Equity

Written

4,600

USD 42.5

American

01/16/26

Common Stock

Call Option IP US 09/19/25 C47.5 Equity

Purchase

100

USD 47.5

American

09/19/25

Common Stock

Call Option IP US 01/17/25 C50 Equity

Purchase

100

USD 50

American

01/17/25

Common Stock

Put Option IP US 01/17/25 P55 Equity

Purchase

100

USD 55

American

01/17/25

Common Stock

Call Option IP US 06/20/25 C45 Equity

Purchase

100

USD 45

American

06/20/25

Common Stock

Call Option IP US 10/17/25 C50 Equity

Purchase

100

USD 50

American

10/17/25

Common Stock

Call Option IP US 06/20/25 C47.5 Equity

Purchase

100

USD 47.5

American

06/20/25

Common Stock

Put Option IP US 01/17/25 P52.5 Equity

Written

100

USD 52.5

American

01/17/25

Common Stock

Put Option IP US 02/21/25 P52.5 Equity

Written

200

USD 52.5

American

02/21/25

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk

Contacts

Qube Research & Technologies LTD

Qube Research & Technologies LTD

LSE:0JCB

Release Versions

Contacts

Qube Research & Technologies LTD

More News From Qube Research & Technologies LTD

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
Back to Newsroom